ARF6 and neoplasm: Compared with previous articles [14], the novelty of this study lies in the confirmation that XIST downregulation might inhibit tumor migration, invasion, and glycolysis, and the construction of a novel network mechanism of the XIST-miR-320d-ARF6 axis.